Hepatitis B Virus Drug Resistance, Genotype, and BCP/Precore Mutations
Use
This test is used to identify HBV genotype (A–H) for epidemiologic or prognostic purposes and to detect hepatitis B virus mutations associated with resistance to antiviral agents.
Special Instructions
Reliable performance requires specimens with a viral load of at least 600 IU/mL. Schedule: Monday and Thursday. Performing lab: Quest Diagnostics San Juan Capistrano.
Limitations
This test can only be performed reliably on specimens with a viral load of at least 600 IU/mL. It was developed and its analytical performance characteristics have been determined by Quest Diagnostics; it has not been FDA cleared or approved but is validated and used under CLIA regulations.
New York Approved
Methodology
PCR-based (PCR)
Biomarkers
Result Turnaround Time
8 days
Related Documents
For more information, please review the documents below
Specimen
Plasma
Volume
1 mL serum or plasma
Minimum Volume
0.3 mL serum or plasma
Container
Lavender (EDTA) tube or serum separator tube (red-top)
Collection Instructions
Separate serum or plasma within 2 hours of collection.
Causes for Rejection
Unspun specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 72 hours |
| Refrigerated | 7 days |
| Frozen | 30 days |
Other tests from different labs that may be relevant